DAEWOONG PHARMA
Develops and manufactures drugs, biologics, and active pharmaceutical ingredients.
069620 | KO
Overview
Corporate Details
- ISIN(s):
- KR7069620003
- LEI:
- Country:
- South Korea
- Address:
- 경기도 화성시 향남읍 제약공단4길 35-14, 화성시
- Sector:
- Manufacturing
Description
Daewoong Pharma is an R&D-centric pharmaceutical company specializing in the development, manufacturing, and commercialization of medical products. The company's portfolio encompasses prescription drugs, with a focus on gastrointestinal and endocrine therapies, alongside biologics, healthcare products, and active pharmaceutical ingredients (APIs). A core tenet of its business model is 'Open Collaboration,' actively seeking partnerships with academic and industry entities to foster innovation. Daewoong Pharma's research efforts are directed towards breakthrough therapies, utilizing advanced drug delivery technologies and expertise in biologics. The company also offers integrated formulation and manufacturing services, supporting partners from initial development to commercial production.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-03-18 00:00 |
단일판매ㆍ공급계약체결
|
Korean | 9.4 KB | ||
| 2021-03-18 00:00 |
주요사항보고서(자기주식처분결정)
|
Korean | 27.7 KB | ||
| 2021-03-18 00:00 |
사업보고서 (2020.12)
|
Korean | 686.6 KB | ||
| 2021-03-11 00:00 |
감사보고서제출
|
Korean | 18.7 KB | ||
| 2021-03-11 00:00 |
현금ㆍ현물배당결정
|
Korean | 8.4 KB | ||
| 2021-03-11 00:00 |
주주총회소집결의
|
Korean | 18.2 KB | ||
| 2021-03-11 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.2 KB | ||
| 2021-03-11 00:00 |
주주총회소집공고
|
Korean | 259.9 KB | ||
| 2021-03-11 00:00 |
의결권대리행사권유참고서류
|
Korean | 268.1 KB | ||
| 2021-02-22 00:00 |
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 29.4 KB | ||
| 2021-02-15 00:00 |
영업(잠정)실적(공정공시)
|
Korean | 13.5 KB | ||
| 2021-02-15 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 14.0 KB | ||
| 2021-01-25 00:00 |
투자판단관련주요경영사항(코로나치료제 DWJ1248의 COVID-19 예방 목적 임상3상 시험계획 승인)
|
Korean | 8.4 KB | ||
| 2020-12-17 00:00 |
투자판단관련주요경영사항
|
Korean | 8.2 KB | ||
| 2020-12-17 00:00 |
기타경영사항(자율공시)
|
Korean | 5.8 KB |
Automate Your Workflow. Get a real-time feed of all DAEWOONG PHARMA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DAEWOONG PHARMA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DAEWOONG PHARMA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
